A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral...
Relapsed or Refractory Peripheral T-cell and NK/T-cell LymphomaThis is a single-arm, open, multi-center, phase II study to evaluate the efficacy and safety of Mitoxantrone Hydrochloride Liposome Injection in Relapsed or refractory peripheral t-cell and NK/T-cell lymphoma.
Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide...
Peripheral T Cell LymphomaThe PIGLETS regimen was devised to replace the conventional SMILE regimen in management of extranodal NK/T cell lymphoma in our institution. It had been three years since the introduction of PIGLETS regimen in treatment of NK malignancies. The response rate is encouraging, with an overall response rate (ORR) of 90% in NK malignancies. Side effects are generally tolerable. The investigator therefore propose the use of PIGLETS on newly diagnosed or relapsed/refractory PTCLs.
GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma
LymphomaExtranodal NK-T-CellThis study is to explore the efficacy and safety of GLIDE regiment in patients with aggressive NK/T cell lymphoma.
Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell...
Peripheral T-cell LymphomaPrimary objective of the study is to compare the efficacy and safety of decitabine plus CHOP (D-CHOP) versus CHOP alone in patients with previously untreated peripheral T-cell lymphoma (PTCL).
Tofacitinib Combined With Chidamide in R/R ENKTCL
Extranodal NK/T-cell LymphomaThis study is to explore the efficacy and safety of tofacitinib combined with chidamide in patients with relapsed and refractory extranodal NK/T cell lymphoma.
Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma
Peripheral T Cell LymphomaThe purpose of this study is to evaluate the efficacy and safety of Chidamide with ICE regimen in patients with relapsed/refractory Peripheral T Cell lymphoma.
Study of Apatinib and MASCT in Patients With Advanced Solid Tumors
Advanced Solid TumorsExcluding T Cell LymphomaThe study is aimed to evaluate the efficacy and safety of Apatinib and MASCT in patients with advanced solid tumors.
CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma
Acute Myeloid LeukemiaPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma9 moreThe purpose of this study is to evaluate the safety and effectiveness of CAR-pNK cell immunotherapy in patients with CD7 positive relapsed or refractory Leukemia and Lymphoma.
A Study of SHC014748M in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma
Peripheral T Cell LymphomaThe purpose of this study is to evaluate the efficacy and safety of SHC014748M in patients with relapsed or refractory relapsed or refractory Peripheral T Cell Lymphoma.
Lenalidomide and Sintilimab for Relapsed/Refractory NK/T-cell Lymphoma
NK/T Cell Lymphoma NosThe purpose of this study is to evaluate the efficacy and safety of Sintilimab in combination with lenalidomide in the treatment of Relapsed/Refractory NK/T-cell lymphoma patients who failed pegaspargase-based regimens.